mountain girl
Tutor
Offline
I Love YaBB 2!
Posts: 45
|
This was posted on another mast cell forum. Dr. Afrin explains in simple terms the difference between Masto and MCAS. Also how everything is categorized under MCAD.
Mastocytosis in any form -- the rare cutaneous forms such as UP or TMEP, or the even rarer systemic forms -- is a disease of inappropriate mast cell activation combined with inappropriate mast cell proliferation (growth). MCAS, on the other hand, is a disease of inappropriate mast cell activation but with little to no inappropriate mast cell proliferation. Thus, as you can see, it's now evident that *all* mast cell diseases feature inappropriate mast cell activation, but only mastocytosis *also* features inappropriate mast cell proliferation. This is why the new "top-level" term for the whole class of mast cell diseases is "mast cell activation disease" (MCAD). MCAD encompasses both mastocytosis in all its forms as well as MCAS. Current terminology systems in this area say that if you have a diagnosis of UP (or any other form of mastocytosis), then you can't also have a diagnosis of MCAS -- but that's all pretty much an irrelevant semantic point. The bottom line remains two determinations: do you have chronic inappropriate mast cell activation, and do you have chronic inappropriate mast cell growth? (Note that if you have the latter, you virtually certainly also have the former.) Inappropriate activation gets managed with one particular approach (therapies aimed at blocking mediator production, blocking mediator release, and blocking the effects of mediators that have already been released), while inappropriate growth gets treated with a largely different approach (drugs and other techniques that impede mast cell reproduction). The two approaches, of course, are not mutually exclusive, and there are some patients with more aggressive forms of mastocytosis who do in fact get treated simultaneously with both approaches. In many cases of mastocytosis in which there is "less aggressive" inappropriate mast cell growth, though, only therapies targeted at inappropriate mast cell activation are needed.
Overall, the mast cell diseases are highly variable from one patient to the next, thereby requiring that the approach(es) to treatment be as individualized as are the clinical presentations.
-- LBA
|